Epigenetic drug discovery: targeting DNA methyltransferases.
about
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesEpigenetic control of HIV-1 post integration latency: implications for therapyEvidence for the involvement of epigenetics in the progression of renal fibrogenesisTrials with 'epigenetic' drugs: an updateEpigenetic modulators as therapeutic targets in prostate cancerMolecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTsHigh-Throughput Analysis of Global DNA Methylation Using Methyl-Sensitive Digestion5-Aza-2'-deoxycytidine inhibited PDGF-induced rat airway smooth muscle cell phenotypic switchingHEDD: the human epigenetic drug databaseTranscriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective mannerDiscovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cellsPerspectives on the discovery of small-molecule modulators for epigenetic processes.Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancerInduction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney DiseaseTime-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2.Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.DNA Methylation Modulates Nociceptive Sensitization after Incision.Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the PromoterDesign, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation.Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine.TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.Epigenetic mechanisms in commonly occurring cancers.Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cellsMolecular characteristics and chromatin texture features in acute promyelocytic leukemia.Epigenetics as a therapeutic target in breast cancer.Distinctive Roles of 5-aza-2'-deoxycytidine in Anterior Agranular Insular and Basolateral Amygdala in Reconsolidation of Aversive Memory Associated with Morphine in Rats.Identification of DNMT1 selective antagonists using a novel scintillation proximity assay.Epigenetics and colorectal cancer pathogenesisSpecific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor GrowthGenistein mediates the selective radiosensitizing effect in NSCLC A549 cells via inhibiting methylation of the keap1 gene promoter regionReduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation.DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences.The role of promoter hypermethylation in fibroblast activation and fibrogenesis.Drugging the undruggable: transcription therapy for cancer.Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas.Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.Rationalization of activity cliffs of a sulfonamide inhibitor of DNA methyltransferases with induced-fit docking.SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.Driver mutations of cancer epigenomes.
P2860
Q26744080-6B997B89-F5F3-41B0-80B8-46315DBA7544Q26781191-448C1389-9DC0-4150-A3A4-EA2CD53BCE2CQ26827293-E04C7DB4-EDF4-4E56-9591-4E61EFDB8BF2Q27000542-3B9D640A-E143-4570-AF28-A519198A0531Q28071912-0A7A6D35-8299-479B-9BD4-01F402E62424Q28487027-BB72CEAC-FE56-4AFB-B06B-D999F4D73707Q28552727-0BF9AC1A-76C2-4944-B372-D5C06F4C6739Q28576398-D6D8293A-BDCA-41FA-BC6C-799B509D8024Q28818364-468C2909-7A4A-41C8-AF97-1C741AF9148FQ33585948-F4F51CB1-E79B-4EC6-81CE-D9F88D98CC39Q33762936-11CD2853-4A81-4E17-A930-E3C037198072Q33934590-C82B719B-EE33-497C-BE42-12E4C958A9A1Q34185471-774AC127-2D35-4F56-864F-30F8504ACFACQ34654640-DE958EA0-A20A-45CE-B568-122019255610Q35110633-CB49200E-256E-4982-AC5F-9017D936D48BQ35114405-B4060FB4-3EE9-4D7C-9B82-3B7146529B24Q35794392-2E109D5D-F3C4-4965-9824-1B9C27DE0EBDQ35831786-A79FAE42-7461-4038-A4F6-B6B6C36A46CEQ35833292-194DBC6B-8C76-4D42-A4B6-861C3F72ECA1Q35863536-A5EC8CAC-38E1-4FC0-B2F0-F4A6631CFEEBQ35870211-2E78647B-BF8B-4CB7-80DB-7563636658D6Q36213724-0B36DA60-5E89-47D8-9AB9-0B85F6CFA299Q36286662-B53C93D3-5986-4132-8A45-3666395D9629Q36292011-595EC116-1DF9-4BED-BC87-6EA08E2FF136Q36338616-570AF6C4-E9F2-4441-BC40-8DF446B2CAAAQ36449057-3B4DC45E-B3D1-4FA7-A193-827CC8B945BDQ36685797-1618E9BE-6006-4AA2-ADED-F87D3359DEF2Q37000576-0D6C640A-5C40-4E15-959B-E49FFA13DB75Q37061792-09A4D694-B1F1-4106-8A29-5063ADA6F812Q37290420-252BEC80-3080-49E6-9BEE-E33B7E19F0B0Q37317230-8489DEDD-2864-4B3D-BDEC-4A384DCA0991Q37600049-7617B42C-FEF0-4BF4-B6C0-7FED4595D320Q38040883-FEA0B6D8-BE0F-4D4A-AB25-42D6EAA88D82Q38055432-0623F8CA-AD95-477E-BBA3-E995B2A27930Q38059387-A09B6173-874A-4264-BBDB-975C970BE1B7Q38112248-8AD29C21-9BC9-4EC7-A5B8-CC817E866307Q38141135-148FF3D7-B97B-4F4D-853A-01D043254A7AQ38346032-C1DD9770-1503-4AD9-A9FB-08139DDF19BDQ38625953-71A6AA8F-4E54-4E55-A036-CAAE45F41B78Q38639828-FB2136CA-F0EB-4264-9B71-052E46A1E8E1
P2860
Epigenetic drug discovery: targeting DNA methyltransferases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic drug discovery: targeting DNA methyltransferases.
@en
Epigenetic drug discovery: targeting DNA methyltransferases.
@nl
type
label
Epigenetic drug discovery: targeting DNA methyltransferases.
@en
Epigenetic drug discovery: targeting DNA methyltransferases.
@nl
prefLabel
Epigenetic drug discovery: targeting DNA methyltransferases.
@en
Epigenetic drug discovery: targeting DNA methyltransferases.
@nl
P2093
P2860
P356
P1476
Epigenetic drug discovery: targeting DNA methyltransferases.
@en
P2093
Jason M Foulks
K Mark Parnell
Kevin Wright
Koc-Kan Ho
Krzysztof Swierczek
Michael Saunders
Michael V McCullar
Rebecca N Nix
Steven B Kanner
Suzanna Chau
P2860
P356
10.1177/1087057111421212
P577
2011-09-30T00:00:00Z